Compare TNDM & EFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TNDM | EFC |
|---|---|---|
| Founded | 2006 | 2007 |
| Country | United States | United States |
| Employees | N/A | 400 |
| Industry | Medical/Dental Instruments | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.6B |
| IPO Year | 2013 | 2010 |
| Metric | TNDM | EFC |
|---|---|---|
| Price | $19.27 | $13.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 6 |
| Target Price | ★ $24.35 | $14.54 |
| AVG Volume (30 Days) | 1.3M | ★ 2.6M |
| Earning Date | 02-19-2026 | 02-26-2026 |
| Dividend Yield | N/A | ★ 12.00% |
| EPS Growth | N/A | ★ 1.22 |
| EPS | N/A | ★ 1.33 |
| Revenue | ★ $1,007,001,000.00 | $329,815,000.00 |
| Revenue This Year | $8.59 | N/A |
| Revenue Next Year | $10.28 | $8.81 |
| P/E Ratio | ★ N/A | $9.76 |
| Revenue Growth | ★ 17.87 | 13.84 |
| 52 Week Low | $9.98 | $11.12 |
| 52 Week High | $37.71 | $14.40 |
| Indicator | TNDM | EFC |
|---|---|---|
| Relative Strength Index (RSI) | 38.55 | 36.62 |
| Support Level | $18.90 | $12.37 |
| Resistance Level | $20.96 | $12.99 |
| Average True Range (ATR) | 1.05 | 0.25 |
| MACD | -0.15 | -0.09 |
| Stochastic Oscillator | 14.95 | 31.91 |
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on Tobi (a tubeless version of Mobi), and the Sigi tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 2 to 3 days.
Ellington Financial Inc is a specialty finance company. Its primary investment objective is to generate attractive, risk-adjusted total returns for its shareholders by making investments. The company has two reportable segments; The Investment Portfolio Segment is focused on investing in a diverse array of financial assets, including residential and commercial mortgage loans, residential mortgage-backed securities, non-mortgage- and mortgage-related derivatives, debt and equity investments in loan origination companies, and other strategic investments, and The Longbridge Segment is focused on the origination and servicing of reverse mortgage loans. it acquires reverse mortgage loans both through its origination activities and through secondary market purchases.